MedPath

Effect PartySmart Variants in alcohol subjects.

Phase 1
Registration Number
CTRI/2021/03/032236
Lead Sponsor
The Himalaya Drug Company
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Males aged between 20-45 years, weighing more than 45 kgs

2Subject who used to drink alcohol regularly (social drink not alcohol abuse) and is willing and able to comply with the alcohol consumption requirements and overnight stay as per the study requirements

3.Subjects judged by the Investigator to be in general good health based on medical history.

4.Subject understands the study procedures and signs the consent forms providing informed consent to participate in the study

Exclusion Criteria

1.Subject suspected for drug or alcohol abuse

2.A medical or psychiatric condition or laboratory abnormality that may increase the risk associated with study participation

3.Subjective sleep duration of less than 3 hours in the night before the test

4.Caffeine, nicotine or alcohol on the day (from midnight) of the test

5.Use of psycho-active drugs during the past 30 days or any treatment that might interfere with the evaluation of the test drug

6.Any drug known to interact with benzodiazepines and related drugs, e.g. antiepileptics, antihistaminics, muscle relaxant drugs, antihypertensive drugs, drugs inhibiting cytochrome P450

7.Any clinically significant disorder that might interfere with his/her participation in this study and the evaluation of the efficacy or safety of the test drug (e.g. renal insufficiency, hepatic or metabolic dysfunction, cardiovascular disease, neurological and or psychiatric disorder etc.)

8.Known hypersensitivity to any of the ingredients of the study drugs

9.Participation in any other clinical trial within the past 30 days

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Change in the blood alcohol and acetaldehyde levels <br/ ><br>2.Clinical symptoms related to alcohol consumption <br/ ><br>3.Assessment of Alcohol Hangover Questionnaire (AHQ) <br/ ><br>Timepoint: 12 hours
Secondary Outcome Measures
NameTimeMethod
Incidence of adverse effects. <br/ ><br> <br/ ><br>Timepoint: 12 Hours
© Copyright 2025. All Rights Reserved by MedPath